Vedolizumab Outperformed Infliximab in Real-World Outcomes
Physician's Weekly
JUNE 15, 2025
The following is a summary of “Treatment sequences, outcomes, healthcare utilization, and costs in patients with inflammatory bowel diseases requiring advanced treatment—real world comparative effectiveness from German claims data,” published in the June 2025 issue of BMC Gastroenterology by Dignass et al.
Let's personalize your content